fda compounding semaglutide crackdown news today 2025 September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Are off-brand versions of popular

However, demand continues to run hot

Second, it raises the question of where the ceiling lies, and whether further receptor additions (such as amylin or FGF21 agonism, both under investigation in combination compounds) will continue the upward trend

Bake until tender for a colorful, portion-controlled meal

Adherence is another major issue one study suggested that roughly two-thirds of patients discontinue GLP-1 therapy within the first year, often due to high costs, gastrointestinal side effects, lack of perceived benefit, or difficulty maintaining lifestyle changes

None of these mean you failed

Before and after comparisons at the three-month mark often show the first truly dramatic visual differences